But the theory falls apart when the company announced in late June or July or even August (who really cares when) that they still plan on pursuing RMAT but only after the FDA creates guidelines. The FDA just released those guidelines and USRM followed through on their promise. They even hired a law firm that specializes in working with the FDA to make things happen. WOOHOO!!!
A pump is to say something extraordinary that is likely not true... Such as the stock will hit $100 by next Wednesday. To follow through on a promise is... just good business.